Horizon Discovery plc Propriété du management
Quel est le Propriété du management de Horizon Discovery plc?
Le Propriété du management de Horizon Discovery Group plc est 10.47%
Quelle est la définition de Propriété du management?
La propriété d'un initié est calculée en divisant le nombre total d'actions possédées par des initiés (actionnaires détenant plus de 5% de la société ou un dirigeant ou un administrateur de la société) par le nombre total d'actions en circulation.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Propriété du management des entreprises dans Health Care secteur sur LSE par rapport à Horizon Discovery plc
Que fait Horizon Discovery plc?
Horizon Discovery Group plc, a cell engineering company, engages in the design, manufacture, and application of gene editing and gene modulation tools in the United Kingdom, the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through Screening, Research Reagents, Diagnostics, and BioProduction segments. It provides custom-made and off-the-shelf (OTS) RNAi gene modulation reagents, CRISPR reagents, synthetic SGRNAs, OTS cell models, and custom cell engineering services. The company also offers pooled CRISPR screens; arrayed RNAi and CRISPR screens, drug screens, and immunology assays; and RNAi and CRISPR screening libraries; and human T-Cell CRISPR screening service to meet the requirements of immunology based research in drug discovery. In addition, it provides OTS gene-edited CHO cells and custom CHO cell lines, and custom CHO gene engineering services; and OTS cell-based reference standards, made to order reference standards, and custom cell-based reference standards to evaluate molecular assays on a research use basis. The company serves customers in academic research labs, biopharmaceutical and diagnostics companies, and contract research and manufacturing organizations. It sells its products through direct field sales channel and e-commerce platform. The company has a partnership with the Rutgers, The State University of New Jersey to develop and commercialize base editing, a gene editing technology; strategic collaboration with Mammoth Biosciences to develop CRISPR tools to provide engineered cell lines for the biopharmaceutical industry; and collaboration with St George's University Hospital, London, and the European Molecular Genetics Quality Network to develop reference material for non-invasive prenatal testing. Horizon Discovery Group plc was founded in 2007 and is headquartered in Cambridge, the United Kingdom.
Entreprises avec propriété du management similaire à Horizon Discovery plc
- BSquare Corp a Propriété du management de 10.46%
- Slate Office REIT a Propriété du management de 10.46%
- Asure Software Inc a Propriété du management de 10.46%
- Letho Resources a Propriété du management de 10.46%
- Aura Resources a Propriété du management de 10.46%
- Vicinity Motor a Propriété du management de 10.47%
- Horizon Discovery plc a Propriété du management de 10.47%
- Cass Information Systems Inc a Propriété du management de 10.48%
- Stratabound Minerals Corp a Propriété du management de 10.48%
- Stratabound Minerals a Propriété du management de 10.48%
- Naked Brand a Propriété du management de 10.49%
- Sonoro a Propriété du management de 10.50%
- Hurricane Plc a Propriété du management de 10.50%